MEASURING MEDICATION ADHERENCE THROUGH MOBILE APPS: A SOCIAL SCIENCE PERSPECTIVE
DOI:
https://doi.org/10.31435/ijitss.3(47).2025.3894Keywords:
Medication Adherence, Chronic Disease, Electronic Monitoring, mHealth, Video Observed Therapy (VOT), Digital HealthAbstract
Medication adherence is a critical factor influencing the effectiveness of chronic disease management and overall public health outcomes. Despite advances in pharmacotherapy and the availability of effective medications, adherence rates among patients with chronic illnesses remain suboptimal, often as low as 50%, and even lower for asymptomatic conditions such as hypertension. Poor adherence not only reduces the potential benefits of therapy but also contributes to disease progression, increased morbidity, frequent hospitalizations, and substantial financial burdens on healthcare systems. This review provides a comprehensive overview of current methods for measuring medication adherence, including traditional approaches such as self-report, pill count, and clinician assessment, as well as advanced technological solutions like electronic medication packaging (EMP) devices, mobile health (mHealth) applications, video observed therapy (VOT), and ingestible biosensors.
The discussion highlights the strengths and limitations of each method, emphasizing that no single approach is flawless and that a multidimensional strategy often yields the most reliable results. Patient-related factors such as knowledge, beliefs, psychological state, and the quality of the patient-provider relationship are identified as key influences on adherence behavior. Socioeconomic variables, cognitive impairment, and regimen complexity further complicate adherence, especially in older adults and vulnerable populations. Recent advances in digital health offer promising avenues for real-time monitoring and tailored interventions, but challenges remain regarding accessibility, cost, user engagement, and data privacy.
The review concludes that improving medication adherence may have a more profound impact on public health than developing new therapies. Effective solutions require a holistic approach that integrates reliable measurement, patient-centered care, technological innovation, and system-level support. Ongoing research, collaboration across disciplines, and policy efforts are crucial to bridging the gap between prescribed treatments and real-world patient behavior, ultimately improving health outcomes and reducing healthcare expenditures.
References
Adisa, R., Alutundu, M. B., & Fakeye, T. O. (2009). Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharmacy Practice, 7(3), 163–169. https://doi.org/10.4321/s1886-36552009000300007
Alsabbagh, M. H., Lemstra, M., Eurich, D., Lix, L. M., Wilson, T. W., Watson, E., & Blackburn, D. F. (2014). Socioeconomic status and nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Value in Health, 17(2), 288–296. https://doi.org/10.1016/j.jval.2013.11.011
Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., Vecchiet, J., D’Arminio Monforte, A., Wu, A. W., & Antinori, A. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. JAIDS Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S123–S127. https://doi.org/10.1097/00126334-200212153-00007
Arlt, A. D., Nestoriuc, Y., & Rief, W. (2017). Why current drug adherence programs fail: addressing psychological risk factors of nonadherence. Current opinion in psychiatry, 30(5), 326–333. https://doi.org/10.1097/YCO.0000000000000345
Armitage, L. C., Kassavou, A., & Sutton, S. (2020). Do mobile device apps designed to support medication adherence demonstrate efficacy? A systematic review of randomised controlled trials, with meta-analysis. BMJ Open, 10(1), e032045. https://doi.org/10.1136/bmjopen-2019-032045
Barat, I., Andreasen, F., & Damsgaard, E. M. (2001). Drug therapy in the elderly: What doctors believe and patients actually do. British Journal of Clinical Pharmacology, 51(6), 615–622. https://doi.org/10.1046/j.0306-5251.2001.01401.x
Berg, J. S., Dischler, J., Wagner, D. J., Raia, J. J., & Palmer-Shevlin, N. (1993). Medication compliance: A healthcare problem. Annals of Pharmacotherapy, 27(Suppl 9), S1–S24.
Blum, M. A., Koo, D., & Doshi, J. A. (2011). Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: A systematic review. Clinical Therapeutics, 33(7), 901–913. https://doi.org/10.1016/j.clinthera.2011.06.001
Browne, S. H., Peloquin, C., & Santillo, F. (2018). Digitizing medicines for remote capture of oral medication adherence using co-encapsulation. Clinical Pharmacology & Therapeutics, 103(3), 502–510. https://doi.org/10.1002/cpt.910
Butow, P., & Sharpe, L. (2013). The impact of communication on adherence in pain management. Pain, 154(Suppl 1), S101–S107. https://doi.org/10.1016/j.pain.2013.07.048
Campbell, N. L., Zhan, J., Tu, W., Weber, Z., Ambeuhl, R., McKay, C., & McElwee, N. (2016). Self-reported medication adherence barriers among ambulatory older adults with mild cognitive impairment. Pharmacotherapy, 36(2), 196–202. https://doi.org/10.1002/phar.1702
Chakrabarti, S. (2014). What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World Journal of Psychiatry, 4(2), 30–36. https://doi.org/10.5498/wjp.v4.i2.30
Chandrika, K., Das, B. N., Syed, S., & Challa, S. (2020). Diabetes self-care activities: A community-based survey in an urban slum in Hyderabad, India. Indian Journal of Community Medicine, 45(3), 307–310. https://doi.org/10.4103/ijcm.IJCM_19_20
de Klerk, E., van der Heijde, D., Landewé, R., van der Tempel, H., Urquhart, J., & van der Linden, S. (2003). Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. Journal of Rheumatology, 30(1), 44–54.
Dew, M. A., Dabbs, A. D., & Myaskovsky, L. (2009). Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation, 88(5), 736–746. https://doi.org/10.1097/TP.0b013e3181b2a0e0
Dukes, C. K., & Sheaffer, E. A. (2021). Biosensing technology to track adherence: A literature review. Healthcare, 9(10), 1339. https://doi.org/10.3390/healthcare9101339
El Alili, M., Vrijens, B., & Demonceau, J. (2016). A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. British Journal of Clinical Pharmacology, 82(1), 268–279. https://doi.org/10.1111/bcp.12942
Farin, E., Gramm, L., & Schmidt, E. (2013). Predictors of communication preferences in patients with chronic low back pain. Patient Preference and Adherence, 7, 1117–1127. https://doi.org/10.2147/PPA.S50695
Feinstein, A. R. (1990). On white-coat effects and the electronic monitoring of compliance. Archives of Internal Medicine, 150(7), 1377–1378. https://doi.org/10.1001/archinte.1990.00390190117024
Free, C., Phillips, G., Watson, L., Galli, L., Felix, L., Edwards, P., Patel, V., & Haines, A. (2013). The effectiveness of mobile-health technologies to improve health care service delivery processes: A systematic review and meta-analysis. PLoS Medicine, 10(1), e1001363. https://doi.org/10.1371/journal.pmed.1001363
Garfein, R. S., Liu, L., Cuevas-Mota, J., Collins, K., Muñoz, F., Catanzaro, D. G., Moser, K., Higashi, J., Al-Samarrai, T., Kriner, P., Vaishampayan, J., Cepeda, J., Bulterys, M. A., Martin, N. K., Rios, P., & Raab, F. (2018). Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA. Emerging Infectious Diseases, 24(10), 1806–1815. https://doi.org/10.3201/eid2410.180459
Gibson, T. B., Song, X., Alemayehu, B., Wang, S. S., Waddell, J. L., Bouchard, J. R., & Forma, F. (2010). Cost sharing, adherence, and health outcomes in patients with diabetes. American Journal of Managed Care, 16(8), 589–600.
Gopichandran, V., Lyndon, S., Angel, M. K., Manayalil, B. P., Blessy, K. R., Alex, R. G., & John, K. R. (2012). Diabetes self-care activities: A community-based survey in urban southern India. National Medical Journal of India, 25(1), 14–17.
Haberer, J. E., Kahane, J., & Kigozi, I. (2010). Real-time adherence monitoring for HIV antiretroviral therapy. AIDS and Behavior, 14(6), 1340–1346. https://doi.org/10.1007/s10461-010-9799-4
Haynes, R. B., Yao, X., Degani, A., Kripalani, S., Garg, A., & McDonald, H. P. (2005). Interventions to enhance medication adherence. Cochrane Database of Systematic Reviews, 4, CD000011. https://doi.org/10.1002/14651858.CD000011.pub2
Hebing, R. C., Aksu, I., & Twisk, J. W. (2022). Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: A randomised clinical trial. RMD Open, 8(1), e001712. https://doi.org/10.1136/rmdopen-2021-001712
Heisig, S. R., Shedden-Mora, M. C., von Blanckenburg, P., Schuricht, F., Rief, W., Albert, U. S., & Nestoriuc, Y. (2015). Informing women with breast cancer about endocrine therapy: Effects on knowledge and adherence. Psycho-Oncology, 24(2), 130–137. https://doi.org/10.1002/pon.3611
Holzman, S. B., Atre, S., Sahasrabudhe, T., Ambike, S., Jagtap, D., Sayyad, Y., Kakrani, A. L., Gupta, A., Mave, V., & Shah, M. (2019). Use of smartphone-based video directly observed therapy (vDOT) in tuberculosis care: Single-arm, prospective feasibility study. JMIR Formative Research, 3(3), e13411. https://doi.org/10.2196/13411
Horsburgh, S., Barson, D., Zeng, J., Sharples, K., & Parkin, L. (2019). Adherence to metformin monotherapy in people with type 2 diabetes mellitus in New Zealand. Diabetes Research and Clinical Practice, 158, 13–19. https://doi.org/10.1016/j.diabres.2019.01.018
Istepanian, R., Laxminarayan, S., & Pattichis, C. S. (Eds.). (2006). M-health: Emerging mobile health systems. Springer.
Istepanian, R. S. H. (2022). Mobile health (m-health) in retrospect: The known unknowns. International Journal of Environmental Research and Public Health, 19(7), 3747. https://doi.org/10.3390/ijerph19073747
Kelley, J. M., Kraft-Todd, G., Schapira, L., Kossowsky, J., & Riess, H. (2014). The influence of the patient-clinician relationship on healthcare outcomes: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE, 9(4), e94207. https://doi.org/10.1371/journal.pone.0094207
Koprulu, F., Bader, R. J. K., Hassan, N., Abduelkarem, A. R., & Mahmood, D. A. (2014). Evaluation of adherence to diabetic treatment in northern region of United Arab Emirates. Tropical Journal of Pharmaceutical Research, 13(6), 989–995. https://doi.org/10.4314/tjpr.v13i6.22
Larsen, K. G., Areberg, J., & Åström, D. O. (2021). Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations? Experiences from a study of antidepressants in healthy volunteers. Clinical Trials, 18(4), 505–510. https://doi.org/10.1177/17407745211004287
Maruan, K., Isa, K. A. M., Sulaiman, N., & Karuppannan, M. (2020). Adherence of patients with type 2 diabetes to refills and medications: A comparison between “telephone and collect” and conventional counter services in a health clinic. Drugs & Therapy Perspectives, 36(12), 590–597. https://doi.org/10.1007/s40267-020-00782-1
McDonnell, P. J., & Jacobs, M. R. (2002). Hospital admissions resulting from preventable adverse drug reactions. Annals of Pharmacotherapy, 36(9), 1331–1336. https://doi.org/10.1345/aph.1A333
McRae-Clark, A. L., Baker, N. L., Sonne, S. C., DeVane, C. L., Wagner, A., & Norton, J. (2015). Concordance of direct and indirect measures of medication adherence in a treatment trial for cannabis dependence. Journal of Substance Abuse Treatment, 57, 70–74. https://doi.org/10.1016/j.jsat.2015.05.002
Mehas, N., Hudmon, K. S., & Jaynes, H. (2021). Impact of electronic medication reminder caps on patient adherence and blood pressure. Journal of Pharmacy Technology, 37(5), 234–243. https://doi.org/10.1177/87551225211002991
Mir, T. H. (2023). Adherence versus compliance. HCA Healthcare Journal of Medicine, 4(2), 219–220. https://doi.org/10.36518/2689-0216.1513
Nestoriuc, Y., von Blanckenburg, P., Schuricht, F., Barsky, A. J., Hadji, P., Albert, U. S., & Rief, W. (2016). Is it best to expect the worst? Influence of patients’ side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Annals of Oncology, 27(10), 1909–1915. https://doi.org/10.1093/annonc/mdw266
Niaz, D., Necyk, C., & Simpson, S. H. (2021). Depression and antecedent medication adherence in a cohort of new metformin users. Diabetic Medicine, 38(2), e14426. https://doi.org/10.1111/dme.14426
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487–497. https://doi.org/10.1056/NEJMra050100
Partridge, A. H. (2006). Non-adherence to endocrine therapy for breast cancer. Annals of Oncology, 17(2), 183–184. https://doi.org/10.1093/annonc/mdj141
Pham, S. T., Nguyen, T. A., & Tran, N. M. (2023). Medication adherence in cardiovascular diseases. In Novel pathogenesis and treatments for cardiovascular disease. IntechOpen. https://doi.org/10.5772/intechopen.108181
Raum, E., Krämer, H. U., Rüter, G., Rothenbacher, D., Rosemann, T., Szecsenyi, J., & Brenner, H. (2012). Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 97(3), 377–384. https://doi.org/10.1016/j.diabres.2012.03.023
Riekert, K. A., & Rand, C. S. (2002). Electronic monitoring of medication adherence: When is high-tech best? Journal of Clinical Psychology in Medical Settings, 9(1), 25–34. https://doi.org/10.1023/A:1014131928780
Schäfer-Keller, P., Garzoni, D., Dickenmann, M., & De Geest, S. (2010). Medikamentöse Nicht-Adhärenz – Prädiktive Faktoren und Diagnostik [Medication non-adherence – Predictive factors and diagnostics]. Therapeutische Umschau, 67(6), 283–288. https://doi.org/10.1024/0040-5930/a000051
Schubert, C. C., Boustani, M., Callahan, C. M., Perkins, A. J., Carney, C. P., Fox, C., Unverzagt, F., Hui, S., & Hendrie, H. C. (2006). Comorbidity profile of dementia patients in primary care: Are they sicker? Journal of the American Geriatrics Society, 54(1), 104–109. https://doi.org/10.1111/j.1532-5415.2005.00543.x
Senst, B. L., Achusim, L. E., Genest, R. P., Cosentino, L. A., Ford, C. C., Little, J. A., Ray, H. E., & Bates, D. W. (2001). Practical approach to determining costs and frequency of adverse drug events in a health care network. American Journal of Health-System Pharmacy, 58(12), 1126–1132. https://doi.org/10.1093/ajhp/58.12.1126
Shams, M. E. E., & Barakat, E. A. M. E. (2010). Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharmaceutical Journal, 18(4), 225–232. https://doi.org/10.1016/j.jsps.2010.07.004
Suzuki, R., Saita, S., Nishigaki, N., Kisanuki, K., Shimasaki, Y., Mineyama, T., & Fukui, K. (2021). Factors associated with treatment adherence and satisfaction in type 2 diabetes management in Japan: Results from a web-based questionnaire survey. Diabetes Therapy, 12(9), 2343–2358. https://doi.org/10.1007/s13300-021-01113-8
Thanh Pham, S., Anh Nguyen, T., & Minh Tran, N. (2023). Medication adherence in cardiovascular diseases. In Novel pathogenesis and treatments for cardiovascular disease. IntechOpen. https://doi.org/10.5772/intechopen.108181
Thatipelli, S., Arun, A., Chung, P., & Etemadi, M. (2016). Review of existing brace adherence monitoring methods to assess adherence. Journal of Prosthetics and Orthotics, 28(4), 126–135. https://doi.org/10.1097/JPO.0000000000000106
Urquhart, J. (1997). The electronic medication event monitor: Lessons for pharmacotherapy. Clinical Pharmacokinetics, 32(5), 345–356. https://doi.org/10.2165/00003088-199732050-00001
Urquhart, J. (2002). The odds of the three nons when an aptly prescribed medicine isn’t working: Non-compliance, non-absorption, non-response. British Journal of Clinical Pharmacology, 54(2), 212–220. https://doi.org/10.1046/j.1365-2125.2002.01633.x
van den Bemt, B. J., Zwikker, H. E., & van den Ende, C. H. (2012). Medication adherence in patients with rheumatoid arthritis: A critical appraisal of the existing literature. Expert Review of Clinical Immunology, 8(4), 337–351. https://doi.org/10.1586/eci.12.23
de Klerk, E., van der Heijde, D., Landewé, R., van der Tempel, H., Urquhart, J., & van der Linden, S. (2003). Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. Journal of Rheumatology, 30(1), 44–54.
Viller, F., Guillemin, F., Briançon, S., Moum, T., Suurmeijer, T., & van den Heuvel, W. (1999). Compliance to drug treatment of patients with rheumatoid arthritis: A 3-year longitudinal study. Journal of Rheumatology, 26(10), 2114–2122.
Wroe, A. L. (2002). Intentional and unintentional nonadherence: A study of decision making. Journal of Behavioral Medicine, 25(4), 355–372. https://doi.org/10.1023/a:1015866415552
Zolnierek, K. B. H., & DiMatteo, M. R. (2009). Physician communication and patient adherence to treatment: A meta-analysis. Medical Care, 47(8), 826–834. https://doi.org/10.1097/MLR.0b013e31819a5acc
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
